Avgustinova et al. Supplementary Material 1/12 Supplementary Figure 1. Characterisation of the stroma in 4T1 series tumours. (a) Representative low power images of tumour sections described in Fig. 1a stained with αSMA-FITC (green) and endosialin followed by Alexa555-anti-rabbit-IgG (red). Nuclei were counterstained with DAPI (blue). Scale bar, 150 µm. Dashed line indicates border between tumour (T) and stroma (S). (b) As both endosialin and αSMA are also expressed by tumour pericytes 1 , sections shown in panel (a) were additionally stained with the endothelial marker endomucin followed by Alexa633-anti-rat-IgG (green) and endosialin followed by Alexa555anti-rabbit-IgG (red). Nuclei were counterstained with DAPI (blue). Representative confocal images are shown. Arrowheads indicate blood vessels. Scale bar, 150 µm. The low incidence of endosialin-positive cells associated with endomucin-positive vessels indicates that the infiltrating endosialin-positive cells are predominantly of fibroblast identity. Avgustinova et al. Supplementary Material 2/12 Supplementary Figure 2 . Characterisation of 4T07 tumours supplemented with recombinant growth factors. 4T07 orthotopic tumours were treated in vivo with recombinant growth factors (see Fig. 2a,b) . (a) Mean tumour weight at necroscopy ± SEM. Groups were compared with one-way ANOVA followed by Bonferroni post-test and no statistically significant differences were found. (b) Images shown in Fig. 2b separated to visualise individual antibody staining. Scale bar, 100 µm. (c) Sections from tumours injected with PBS or recombinant Wnt7a were stained for Wnt7a. Representative immunohistochemical images are shown. Scale bar, 100 µm.
(a) NF#1 and NIH-3T3 fibroblasts were starved overnight in serum free Advanced DMEM and treated with BSA, Wnt7a (100 ng ml -1 ), Wnt3a (50 ng ml -1 ) or the GSK-3β inhibitor SB216763 (10 µM) for 5 hours. Cells were fixed and stained for β-catenin (green). Scale bar, 50 µm. (b) β-catenin transcriptional activation in NF#1 and NIH-3T3 fibroblasts was monitored using the TOPflash assay for 24 h. Comparisons to BSA were made using Student's t-test. (c) NF#1 and NIH-3T3 fibroblasts were starved overnight and then treated with Wnt7a (100 ng ml -1 ) for the indicated times and subject to immunoblotting. Molecular size markers are in kDa.
Supplementary Figure 5. Wnt7a increases NIH-3T3 fibroblast contractility in a TGFβ
receptor-dependent manner. (a) NIH-3T3 fibroblasts embedded in a collagen/Matrigel gels were treated with BSA or Wnt7a (100 ng ml -1 ) in presence or absence of ALK5 inhibitor SB43152 (10 µM) for 72 h. Data show quantification of matrix remodelling ± SEM. Groups were compared using two-way ANOVA followed by Bonferroni post-test. ***, p < 0.001. (b) Collagen gels from panel a were fixed, paraffin-embedded and sections were stained with antibodies against the pan-fibroblast marker Endo180 (Mrc2) followed by Alexa 555-antisheep-IgG (red) and phospho-Smad2 followed by Alexa 488-anti-rabbit-IgG (green). Nuclei were counterstained with DAPI. Upper panel, phospho-Smad2 staining in the fibroblast nuclei was scored as in Fig Fig. 8 , the 347 (Leeds) breast cancer TMA was stained for Wnt7a and αSMA. Wnt7a protein levels were scored as negative/low (n = 203) or high (n = 106). αSMA positive fibroblasts were scored for abundance as 1 (few fibroblasts) or 2 (abundant fibroblasts) and for aSMA expression as 1 (none/little), 2 (intermediate) or 3 (strong). Scores across the triplicate cores were averaged. Shown is the correlation between Wnt7a protein levels and abundance of αSMA-positive fibroblasts and between Wnt7a protein levels and intensity of αSMA staining (unpaired t-test). (b) Correlation of WNT7A expression with the fibroblast core serum response (F-CSR) signature described by Chang et al. 2 in the NKI295 dataset. Gene expression of the 442 probes from NKI295 dataset was used to calculate a module score for each sample. The module score is a weighted averaging as previously described 3 , where n is the number of genes in the signature, Xi represents the normalised gene expression in the sample and gene-specific weights Wi are equal to +1 if the activated fibroblast centroid value of a gene >0, otherwise Wi are equal to −1. WNT7A gene expression was significantly associated with a high F-CSR signature (rho = 0.244, p = 2.56 x 10 -5 ; Spearman correlation). (c) Correlation of WNT7A expression with the fibroblast TGFβ response signature (F-TBRS) described by Calon et al. 4 in the TCGA dataset of 522 primary breast cancers. WNT7A gene expression was significantly associated with a high F-TBRS signature (r = 0.123, p = 0.005; Pearson correlation).
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Supplementary Figure 9 . Uncropped immunoblot images. Uncropped immunoblot images corresponding to Fig. 4b, Fig. 4c and Supplementary Fig. 4c . Molecular size markers are in kDa. 
